Hims & Hers Health: Dont Get Lost In The Weeds Hims & Hers Health remains ultra Bullish despite a near 80% drawdown from 52-week highs, with growth initiatives firmly on…
Hims & Hers Health: Great Vision, Now On Sale - Heres Why Im Upgrading Hims & Hers Health, Inc., faces GLP-1 headwinds, volatility, and regulatory risk but has strong revenue growth and global upside.…
Hims And Hers Weighs GLP 1 Risks Against Global Expansion Plans Hims & Hers Health (NYSE:HIMS) launched a compounded GLP-1 weight-loss medication and withdrew it shortly after following FDA scrutiny.Novo Nordisk…
Hims & Hers Stumbles at the Open as Regulatory Damage Hits 2026 Outlook Hard After reporting earnings yesterday, shares of Hims & Hers Health have fallen not because of fundamentals but rather guidance.…
Hims & Hers Health After The GLP-1 Collapse Hims & Hers Healths revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Click…
Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences - Hims & Hers stock drops after Q4 revenue miss. Outlook trails estimates despite profit beat and strong subscriber growth.…
Earnings live: Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results…
Stocks making the biggest moves premarket: AMD, Home Depot, Hims & Hers Health, Diamondback Energy and more These are the stocks posting the largest moves in early trading.…
Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall Hims & Hers Health (NYSE: HIMS) delivered a beat on both earnings and profitability in Q4 2025, though a soft…
Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall Hims & Hers Health (NYSE: HIMS) delivered a beat on both earnings and profitability in Q4 2025, though a soft…
Hims & Hers Q4 Earnings Show Growth Amid GLP-1 Scrutiny Hims & Hers Health delivered strong FY25 results with 59% revenue growth to $2.35B and 13% subscriber growth, but faces…
These Stocks Are Today’s Movers: Home Depot, Novo Nordisk, Hims & Hers, IBM, BWX, Kratos, Vir, and More Hims & Hers shares sink after the online health platform issues underwhelming guidance for the current quarter.…
Doppelschlag für Hims & Hers: SEC-Ermittlungen und schwacher Ausblick schicken Aktie auf Talfahrt Der US-Telemedizin-Anbieter Hims & Hers hat am Montagabend zwar ein solides Umsatzwachstum für das vierte Quartal 2025 vermeldet. Doch ein…
Stocks to Watch Tuesday: Home Depot, Hims & Hers, Blue Owl ?? Home Depot (HD): The home-improvement retailers quarterly results topped expectations, despite profit falling. The company said it i…
Hims & Hers Health discloses SEC investigation over copycat GLP-1s; stock falls Hims & Hers (HIMS) faces an SEC investigation over compounded semaglutide disclosures as Q4 earnings beat.…
Hims & Hers Health Q4 Earnings Call Highlights Hims & Hers Health (NYSE:HIMS) executives used the company’s fourth-quarter and full-year 2025 earnings call to emphasize expanding scale, broader…
In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on…
Assessing Hims & Hers Health (HIMS) Valuation After The Recent Share Price Pullback What Is Moving Hims & Hers Health (HIMS) Now? Hims & Hers Health (HIMS) has been drawing attention after a…